Setting priorities for HIV/AIDS interventions : a cost-benefit approach
著者
書誌事項
Setting priorities for HIV/AIDS interventions : a cost-benefit approach
E. Elgar, c2010
大学図書館所蔵 全1件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references (p. 207-214) and index
内容説明・目次
内容説明
HIV/AIDS is much too complex a phenomenon to be understood only by reference to common sense and ethical codes. This book presents the cost?benefit analysis (CBA) framework in a well-researched and accessible manner to ensure that the most important considerations are recognized and incorporated. This book argues that HIV/AIDS policies need to be evidence based and that CBA is the best way to assemble and summarize the evidence. The work explains why CBA is needed and highlights a number of myths, misinformation and counterintuitive results in the field, and critiques the Millennium Development Goals approach. It also presents HIV/AIDS as a hunger issue in sub-Saharan Africa and as a sexual transmission problem in the US. The roles of nutrition, income, education, religion, agricultural policy, concurrency and sexual networks are all examined. Robert Brent explains the main cost?benefit methods and applications, including threshold analysis, willingness to pay, cost minimization, cost-effectiveness, human capital theory and the value of a statistical life. Applications cover female education, possible vaccines, condoms, and various forms of treatment. He concludes by explaining how CBA incorporates social considerations such as equity.With timely and controversial discussions, this book will be read with interest by AIDS activists, NGO members, policy-makers and public officials, as well as being accessible to non-economists interested in the subject of HIV/AIDS.
目次
Contents:
Preface
PART I: WHY COST-BENEFIT ANALYSIS IS NEEDED TO SET HIV/AIDS PRIORITIES
1. Introduction to the Book
2. Why Not Just Simply do What is Right and Try to Save Lives?
3. Myths and Misinformation
4. Counterintuitive Results
5. What is Wrong with Setting any Targets?
6. What is Wrong with Setting the Particular MDG Targets?
7. Cost-Benefit Analysis 101
8. Cost-Benefit Analysis 201
PART II: HIV/AIDS AS A HUNGER AND ECONOMIC DEVELOPMENT ISSUE
9. Introduction to Part II
10. HIV and Hunger
11. Nutrition and HIV at the Individual Level
12. Nutrition and HIV at the Country Level
13. Income as a Factor Raising HIV Rates
14. Education as a Factor Raising HIV Rates
15. Islam as a Factor Lowering HIV Rates
16. Impact of HIV on Agricultural Households
17. Agricultural Policy and HIV Interventions
18. Sex and HIV I: The Role of Transmission
19. Sex and HIV II: The Role of Concurrency
20. Sex and HIV III: The Role of Networks
PART III: COST-BENEFIT METHODS AND APPLICATIONS
21. Introduction to Part III
22. Threshold Analysis Theory
23. Threshold Analysis Practice: The Effectiveness of HIV Education
24. Threshold Analysis Practice: The Benefits of Avoiding HIV
25. Threshold Analysis Practice: The Costs of a Possible HIV/AIDS Vaccine
26. Willingness to Pay Theory
27. Willingness to Pay Practice: The Benefits of Condoms
28. Cost Minimization Theory
29. Cost Minimization Practice: The Costs of Treating TB
30. Cost-Effectiveness Theory
31. Cost-Effectiveness Practice: The Benefits of ARVs
32. Human Capital Theory
33. Human Capital Practice: The Benefits of Female Primary Education
34. Value of a Statistical Life Theory
35. Value of a Statistical Life Practice: The Benefits of VCT
PART IV: SOCIAL CONSIDERATIONS IN CBA
36. Introduction to IV
37. Commodification: Everything is Seen as a Commodity to be Bought and Sold
38. What is So "Social" About CBA? Fundamentals of CBA
39. Social and Private Perspectives in CBA
40. CBA and Equity I: Allowing for Ability to Pay
41. CBA and Equity II: Allocating by Time and Other Non-Price Methods
42. Conclusions I: How Not to Set Priorities for HIV
43. Conclusions II: Using CBA to Set Priorities for HIV
References
Index
「Nielsen BookData」 より